跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47,456 条关于
“OXB US Inc”
全部
47,456
临床试验
12,648
药物
2,118
机构
6,482
资讯
26,208
去年
Oxford BioMedica Achieves Full Ownership of US Subsidiary to Strengthen Global Gene Therapy Manufacturing Network
2个月前
OXB Selected as GMP Manufacturing Partner for Plowshare Therapies' AAV Gene Therapy Programme Targeting Rare Genetic Diseases
11个月前
Biofrontera Inc. Completes $11M Asset Acquisition of Ameluz and RhodoLED US Rights
去年
FDA Issues Complete Response Letter for Astellas' Izervay sNDA
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
Biofrontera Inc. Negotiates Strategic Partnership Changes with German Parent Company
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Biofrontera Acquires Full US Rights to Ameluz and RhodoLED, Secures $11M Funding
去年
Medipost Expands in US and Canada; Plans US Phase III of Cartistem
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
第 1 页,共 2621 页
上一页
下一页